{"id":"W2163022996","doi":"10.1016/s1474-4422(12)70310-1","title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","year":2013,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Autoimmune Neurological Disorders and Treatments","field":"Medicine","cited_by":3094,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; National Institute of Neurological Disorders and Stroke; National Institute of Mental Health; National Institute on Aging","keywords":"Medicine; Rituximab; Modified Rankin Scale; Immunotherapy; Internal medicine; Encephalitis; Anti-NMDA receptor encephalitis; Plasmapheresis; Cohort; Pediatrics; Immunology; Antibody; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}